Mariana Socal is an Associate Professor of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Carey Business School. Professor Socal researches ways to improve access and affordability of prescription drugs, including the global pharmaceutical supply chain, gene therapies, generics, and biosimilar markets. Professor Socal has testified before the U.S. Congress and the Food and Drug Administration on biopharmaceutical regulation. She is a member of the World Health Organization's Technical Advisory Group on Pricing Policies for Medicines. Professor Socal is a Neurologist. She has a Master’s in Public Policy from Princeton University and a PhD in Health Systems from Johns Hopkins University.

Professor Antonio Trujillo is an applied health economist known for his work on enhancing medication accessibility in the U.S. and globally. He concentrates on strategies to bolster market competition and broaden access to generics and biosimilars. He examines antitrust issues, including "pay for delay" and “mergers,” to decipher the underlying factors contributing to market inefficiencies. Trujillo’s work offers a framework for researchers using the concept of fair pricing in innovative drug pricing policy. Currently, Trujillo researches policies to promote brand-to-brand competition and expedite the introduction of biosimilars. Trujillo is the Director of the Master of Health Science in Global Health Economics program.